The Hybritech Alumni: Where Are They Now?

3/12/10Follow @xconomy

(Page 5 of 6)

Susan Miller, biochemist, Dow Chemical

Carl Mongiovi, vice president, Phamatech [Added: 2:45 pm, 3/15/10]

Deborah Mongiovi, associate director, clinical development, Halozyme Therapeutics [Added: 7 pm, 3/18/10]

Margaret Moore, principal investigator, Imdaptive

Kevin Nakamura, director of research, Astute Medical

Gina Nelson, pharmaceutical market research consultant [Added: 3:10 pm, 3/14/10]

Donna Nichols, investor relations professional

Randy Nielsen, manager of QC and stability, Catalent Pharma Solutions

Tina Nova, co-founder, president and CEO, Genoptix Medical

Susan Nowakowski, president and CEO, AMN Healthcare Services

Janice Ohta, board member, Caltech Associates

Karl Olsen, chief financial officer and head of operations, GNF

Paul O’Shaughnessy, senior marketing manager, off-portal content, AT&T Mobility

Cole Owen, president, Owen & Associates [Added: 1:15 pm 3/12/10]

Bob Parson, vice president of global clinical and regulatory affairs, Inverness Medical Innovations

Jim Patterson, Owner/Partner, System1Search [Added: 8:05 pm, 3/14/10]

Philip Paul, Chairman, Paul Capital Partners [Added: 8:30 pm, 3/14/10]

Melinda (Hackett) Paulis, marketing consultant [Added: 7 pm, 3/18/10]

Greg Payne, director, BD

Liz Perkins, associate director of marketing communications, Prometheus Laboratories

Caryn Peterson, partner, DSC Associates

Leigh Pierce, president and CSO, PacificGMP

Ken Poggenburg, independent pharmaceuticals professional

Norbert Purro, director of pharmaceutical sciences, Pharmacyclics [Added: 3:40 pm, 7/7/10]

Noorul Rahman, consultant at TRL Enterprises

Pamela Resch, director, regulatory affairs, Vical [Added: 9:25 am, 3/15/10]

Lyle Rice, vice president of development, LEAP Biosciences [Added: 10 am, 3/23/10]

Don Rindell, executive director, Amylin Pharmaceuticals

Mark Robertson, owner, Mark Robertson Puppets

Steve Roman, senior scientist, Life Technologies … Next Page »

Single Page Currently on Page: 1 2 3 4 5 6 previous page

By posting a comment, you agree to our terms and conditions.

  • Pingback: The Hybritech Alumni: Where Are They Now? « NCTimes.com Blogs

  • http://www.xconomy.com/author/ltimmerman/ Luke Timmerman

    I’ve been blown away today by the response to this article. My inbox has been overflowing with Hybritech alumni who want to join the list. This story had 110 names when I first published it on Friday, and as of the last update, it’s up to 168 at last count.

    Thanks to David Kabakoff of Sofinnova Ventures for help in finding people, and to all of you who have written to me directly to help strengthen this project. I hope you find it useful.

  • Dave

    Bruce Birch-President, Biosources, Inc.
    Bruce was the facilities manager at Hybritech

  • http://www.xconomy.com/author/ltimmerman/ Luke Timmerman

    Thanks to everybody who’s written in with new names. You’re wearing me out trying to track down all these people, confirming their connection to Hybritech, and their new titles. If people would just like to add comments here with the alumnus’ name, title, and employer, that would be a load off this reporter’s back.

    Again, thanks very much for all the kind words. The positive response has convinced me to do more stories like this.

  • Beth North

    This is a side question really — in your studies, did you come across a little company in the Boston area called Hygia (or some other spelling variant)?

    They were developing some products when Hybritech sued Abbott over patent infringement.

    I think they were acquired shortly after Ames Division, Miles Labs. Inc. (already owned by Bayer AG) decided to end a potential partnership in marketing some of their products.

    This would have been in the 80′s.

    Thanks for any help.

    Beth

  • http://www.xconomy.com/author/ltimmerman/ Luke Timmerman

    Beth–I’m not familiar with Hygia or the patent issue you’re referring to—Luke

  • Jeanne Lenzer

    I’m a journalist working on a story about the development of the PSA test. I’d like to talk with Hybritech alums who were about BEFORE the test was approved by the FDA, who know something about the decision-making process, obstacles, etc., regarding approval.

    Contact me please at jeanne.lenzer@gmail.com or 845.383.1527 thanks.
    Jeanne Lenzer

  • Stacey Riordan

    I worked in research, in the pilot plant. We were isolating antibodies which were targeted with isotopes in the field of cancer, especially liver and breast. We were working with Dr. Stanley Order at John’s Hopkins at that time. I worked as a technician in the class 100 room as well as primary studies leading up to that point.

  • Stacey Riordan

    Worked in Pilot plant with N. Purro and Susan Christianson early 80′s, and some pretty amazing things happened in that lab,,we had some people saved by our “magic bullet”….I am very pleased with my time there…I loved Hybritech and all the people I worked with…very dedicated. Miss you guys, hope all is well.
    Stace

  • victor sabater

    Hi, I was apart of Hybritech from 1996 to 1993 and I would like to join the alumi. What I need is to get in contact with the current HR group (but it looks like the company is no longer in business). If anyone has contact info, please contact me at vsabater@att.net. Thanks guys!

  • Scott Kelsey

    Hello,

    I am a alumni!

    • Chuck Rose

      Yeah you are! How you been boss?

  • Chuck Rose

    Go ahead and add me to that motley crew…Sales & Marketing Work-Study Student…somewhere around 1990-1991 if memory serves…went on to work at the VA Hospital Medical Research, Alliance Pharmaceutical Corp, DepoTech, BioStruct, Hepatix and Millennium Engineering to name a few!

  • pmk

    Parrish Knapp

    Add me to the crew as well. I am around Southern California somewhere. connect with me in Linkedin: http://www.linkedin.com/pub/parrish-knapp/8/709/b0

  • Phil Paul

    You left off Tom Perkin of KPCB, a Board Member and you left off Brook Byers, of KPCB, a Board Member; and you didn’t mention Biovest Partners which I helped Tim Wollaeger and Ted Greene for right after the sale of Hybritech to Eli Lilly………it’s important to the development of the San Diego Healthcare Industry, in that Biosite, Amylin, Cytel, Pyxis and a couple of other very successful Healthcare companies were nurtured by Tim and Ted immediately following Hybritech; in, in my opinion, that’s was really spawned the vibrant Healthcare market around La Jolla/San Diego.
    Phil Paul

  • Tim

    I don’t know if I count or not, haha. I worked as a Temp from a Temp agency harvesting ascites. Went on to Ph.D. and M.D. studies, but now just working in clinical medicine. Loved my time at Hybritech. Great people, and friendly atmosphere. Timothy Tom

  • Pingback: You know you work in San Diego biotech when… | Little Dog Communications